Amivantamab in Combination With Chemotherapy in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)

被引：2

作者：

Nagasaka, M. ^{[1
]}

Goto, K. ^{[2
]}

Gomez, J. ^{[3
]}

Hida, T. ^{[4
]}

Shu, C. ^{[5
]}

Lee, C. K. ^{[6
]}

Park, K. ^{[7
]}

Cho, B. C. ^{[8
]}

Lee, J. ^{[9
]}

Ou, S. ^{[10
]}

Bestvina, C. ^{[11
]}

Natale, R. ^{[12
]}

Haddish-Berhane, N. ^{[13
]}

Bhattacharya, A. ^{[13
]}

Verheijen, R. ^{[13
]}

Agrawal, T. ^{[13
]}

Knoblauch, R. ^{[13
]}

Govindan, R. ^{[14
]}

机构：

[1] Karmanos Canc Inst, Detroit, MI USA

[2] Natl Canc Ctr Hosp East, Kashiwa, Chiba, Japan

[3] Icahn Sch Med Mt Sinai, New York, NY 10029 USA

[4] Aichi Canc Ctr Hosp, Nagoya, Aichi, Japan

[5] Columbia Univ, Med Ctr, New York, NY USA

[6] St George Hosp, Kogarah, NSW, Australia

[7] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Seoul, South Korea

[8] Yonsei Univ, Coll Med, Yonsei Canc Ctr, Seoul, South Korea

[9] Seoul Natl Univ, Bundang Hosp, Seongnam, South Korea

[10] Univ Calif Irvine, Orange, CA 92668 USA

[11] Univ Chicago Med, Chicago, IL USA

[12] Cedars Sinai Med Ctr, Samuel Oschin Comprehens Canc Ctr, Los Angeles, CA 90048 USA

[13] Janssen R&d, Spring House, PA USA

[14] Washington Univ, Sch Med, St Louis, MO USA

来源：

JOURNAL OF THORACIC ONCOLOGY | 2021年 / 16卷 / 10期

关键词：

Amivantamab; EGFR Exon 20 Insertion; Chemotherapy;

D O I：

10.1016/j.jtho.2021.08.532

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

P50.04

引用

页码：S1116 / S1116

页数：1

共 50 条

[1] Chemotherapy for advanced non-small cell lung cancer (NSCLC)
Manegold, C
[J]. LUNG CANCER, 2002, 38 : S47 - S50
[2] Amivantamab Plus Chemotherapy in Non-Small Cell Lung Cancer
不详
[J]. ONCOLOGY-NEW YORK, 2024, 38 (06):
[3] Nimotuzumab in Combination With Chemotherapy in the Patients With Advanced Non-small Cell Lung Cancer
Wang, H.
Li, L.
Zhang, H.
Qian, Z.
Qiu, L.
Li, W.
Liu, X.
[J]. EUROPEAN JOURNAL OF CANCER, 2011, 47 : S630 - S631
[4] Neoadjuvant Chemotherapy for Locally Advanced Non-Small Cell Lung Cancer (NSCLC) Patients
Nakagawa, Taku
Minamiya, Yoshihiro
Saito, Hajime
Imai, Kazuhiro
Konno, Hayato
Kudo, Satoshi
Saito, Yoshitaro
Kurihara, Nobuyasu
Watanabe, Shinnosuke
[J]. JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S685 - S686
[5] Combination chemotherapy including ifosfamide, carboplatin, and cisplatin in advanced non-small cell lung cancer (NSCLC)
Sorensen, JB
Larsen, H
Hansen, HH
[J]. EUROPEAN JOURNAL OF CANCER, 1995, 31A : 1108 - 1108
[6] Cetuximab combination with chemotherapy in advanced non-small cell lung cancer
Duan, Jian-chun
Yang, Lu
Wang, Jie
Zhao, Jun
Wu, Mei-na
An, Tong-tong
[J]. CHINESE JOURNAL OF CANCER RESEARCH, 2009, 21 (04) : 265 - 271
[7] Cetuximab Combination with Chemotherapy in Advanced Non-Small Cell Lung Cancer
Jian-chun Duan~*
[J]. Chinese Journal of Cancer Research, 2009, 21 (04) : 265 - 271
[8] Antiangiogenic Agents in Combination with Chemotherapy in Patients with Advanced Non-Small Cell Lung Cancer
Ulahannan, Susanna V.
Brahmer, Julie R.
[J]. CANCER INVESTIGATION, 2011, 29 (04) : 325 - 337
[9] Combination chemotherapy of gemcitabine and vinorelbine in patients with advanced non-small cell lung cancer
Buyukcelik, A
Utkan, G
Yalcin, B
Demirkazik, A
[J]. LUNG CANCER, 2004, 46 (03) : 377 - 378
[10] CETUXIMAB IN COMBINATION WITH CHEMOTHERAPY IN CHINESE PATIENTS WITH ADVANCED NON-SMALL CELL LUNG CANCER
Si, X-Y
Zhang, Li.
[J]. RESPIROLOGY, 2011, 16 : 133 - 133

← 1 2 3 4 5 →